Pharmacophore-Aware Dual-View Learning with Bidirectional Cross-Attention for Drug-Drug Interaction Prediction

Accurate drug-drug interaction (DDI) prediction is critical for ensuring patient safety and guiding clinical decision-making. Existing methods often rely on single-view molecular representations, limiting their ability to capture the complex structural and spatial properties of drugs. In this study, we propose a novel pharmacophore-aware dual-view learning framework (PharmaDual) that integrates both 2D and 3D representations of pharmacophores for enhanced DDI prediction. Specifically, we first extract pharmacophore fragments as key substructures, and independently encode their 2D and 3D spatial information using specialized graph-and geometry-based encoders. To effectively combine the complementary views, we introduce a bidirectional cross-attention fusion module that dynamically aligns and integrates 2D and 3D pharmacophore representations. Extensive experiments on benchmark DDI datasets demonstrate that our method consistently outperforms existing approaches, highlighting the benefit of dual-view modeling and cross-attentive fusion in capturing nuanced pharmacophore-level interactions. The code is available at https://github.com/ZWX1289/PharmaDual.

Authors

Institutions

Publication Details

Journal
IEEE Access
Published
2025-01-01
DOI
https://doi.org/10.1109/access.2025.3591823
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacophore-Aware Dual-View Learning with Bidirectional Cross-Attention for Drug-Drug Interaction Prediction

Seong-Yoon Shin, Wenxiao Zhang, Hailiang Tang
IEEE Access
Computational Drug Discovery Methods
article

Pharmacophore-Aware Dual-View Learning with Bidirectional Cross-Attention for Drug-Drug Interaction Prediction

Seong-Yoon Shin, Wenxiao Zhang, Hailiang Tang
article en

Abstract

Accurate drug-drug interaction (DDI) prediction is critical for ensuring patient safety and guiding clinical decision-making. Existing methods often rely on single-view molecular representations, limiting their ability to capture the complex structural and spatial properties of drugs. In this study, we propose a novel pharmacophore-aware dual-view learning framework (PharmaDual) that integrates both 2D and 3D representations of pharmacophores for enhanced DDI prediction. Specifically, we first extract pharmacophore fragments as key substructures, and independently encode their 2D and 3D spatial information using specialized graph-and geometry-based encoders. To effectively combine the complementary views, we introduce a bidirectional cross-attention fusion module that dynamically aligns and integrates 2D and 3D pharmacophore representations. Extensive experiments on benchmark DDI datasets demonstrate that our method consistently outperforms existing approaches, highlighting the benefit of dual-view modeling and cross-attentive fusion in capturing nuanced pharmacophore-level interactions. The code is available at https://github.com/ZWX1289/PharmaDual.

IEEE Access
Kunsan National University (KR)
Openalex Percentile: Top 81%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacophore-Aware Dual-View Learning with Bidirectional Cross-Attention for Drug-Drug Interaction Prediction — Seong-Yoon Shin, Wenxiao Zhang, et al. · IEEE Access (2025) | TGRS Research Map | TGRS